Skip to main content

Advertisement

Table 1 Demographic and baseline characteristics of study patients (n = 30)

From: Effect of enhanced external counterpulsation treatment on renal function in cardiac patients

Characteristics  
Age (yr), mean (SD) 69.1 (13.8)
Male 23 (76.7%)
Body mass index (kg/m2) , mean (SD) 26.1 (4.9)
Clinical history  
Coronary artery disease 29 (96.7%)
Hypertension 27 (90.0%)
Diabetes 23 (76.7%)
Stroke 8 (26.7%)
Angina pectoris 23 (76.7%)
Heart failure 7 (23.3%)
Peripheral artery disease 4 (13.3%)
Smoking status 10 (33.3%)
Past smoker 7 (70.0%)
Current smoker 3 (30.0%)
Previous procedures  
Coronary angiography 27 (90.0%)
Percutaneous coronary intervention 12 (40.0%)
Coronary artery bypass grafting 6 (20.0%)
Medication  
Statin 28 (93.3%)
Aspirin or Clopidogrel 27 (90.0%)
ACE inhibitor or ARB 23 (76.7%)
Beta-blocker 19 (63.3%)
Nitrate 17 (56.7%)
Calcium-channel blocker (Diltiazem or Verapamil) 10 (33.3%)
Laboratory findings, mean (SD)  
Hemoglobin (g/dL) 12.9 (1.8)
Albumin (g/dL) 4.2 (0.4)
Cholesterol (mg/dL) 146.0 (27.0)
HDL cholesterol (mg/dL) 49.5 (12.2)
LDL cholesterol (mg/dL) 77.8 (19.6)
Triglyceride (mg/dL) 103.3 (48.7)
Glucose (mg/dL) 118.3 (27.6)
Hemoglobin A1C (%) 7.5 (1.3)
LVEF (%) 55.0 (17.9)